Exaled nitric oxide (FeNO) is considered a good noninvasive marker to assess airway inflammation in asthma and allergic rhinitis. In asthma, exhaled NO is very useful to verify adherence to therapy, and to predict upcoming asthma exacerbations. It has been also proposed that adjusting anti-inflammatory drugs guided by the monitoring of exhaled NO, could improve overall asthma control. Other studies showed increased FeNO levels in subjects with allergic rhinitis.
United airway disease (UAD) hypothesis suggests that asthma and rhinitis are both different clinical manifestation of the same inflammatory process (1) . There is increasing evidence that suggests a major involvement of airway epithelial cells in the pathogenesis of both asthma and allergic rhinitis and this hypothesis have been confirmed by means of epidemiological observations, functional and immunological evidence (2) .
Exhaled nitric oxide is thought to be a sensitive marker of ongoing eosinophilic airway inflammation (3) , and fractional exhaled nitric oxide (FeNO) is particularly attractive for use in children, because it can be measured by using noninvasive and standardized methods and can provide real-time results (4).
EXHALED NITRIC OXIDE AND ASTHMA
Asthma is due to chronic inflammation of the airways involving various cells, mainly eosinophils, mast cells, T lymphocytes, and their mediators (5) . This chronic inflammation damages airway tissue thereby leading to progressive loss of respiratory function, to bronchial hyperresponsiveness (BHR), and to airflow obstruction that result in the typical asthma symptoms, such as wheezing, cough and dyspnea (6, 7) .
The main noninvasive methods for the evaluation of airways inflammation are induced sputum and measurement of fractional exhaled nitric oxide (FeNO). The former is time-consuming, needs a skillful operator, and the results depend on the patient's age and degree of cooperation (8) . Differently, the measurement of FeNO is simple, well tolerated and reproducible (9, 10) . FeNO levels are considered a good noninvasive marker to assess airway inflammation (11) . In fact, they increase during asthma exacerbations (12, 13) , decrease after inhaled steroid therapy (14, 15) , and are higher in atopic asthmatic children than in nonatopic asthmatic children (16) (17) (18) (19) . Furthermore, FeNO is well correlated with eosinophils in bronchoalveolar lavage fluid (20) , in sputum (21) , and in blood (22) .
In asthma, exhaled NO is very useful to verify adherence to therapy (23), and to predict upcoming asthma exacerbations (24) . It is also proposed that adjusting anti-inflammatory medications guided by the monitoring of exhaled NO, could improve overall asthma control (23) .
Atopy seems to be a significant factor associated with a raised exhaled NO independently from asthma (25) . FeNO was most significantlyassociated with the presence of allergic sensitization (26) and specificallergen exposure Key Words: asthma, allergic rhinitis, fractional exhaled nitric oxide and children increased FeNO levels in sensitized, but not in un-sensitized, children (27) . In our experience, FeNO was elevated only in children with asthma and atopic dermatitis who also demonstrated allergic sensitization (28) . The increasing in FENO levels observed in allergic disease is most likely driven by an up-regulation of inducible nitric oxide synthase by cytokines released during airway inflammation (29) . Although Buchvald et al.(30) reported no association between FeNO and atopy as measured by RAST testing in children 2 to 5 years old. Recently, Jackson et al. (25) reported significantly differences in FeNO in atopic versus non-atopic children. A greater elevation of FeNO in older atopic children has been demonstrated in the Buchvald's study (31) suggesting that FeNO values progressively increase with age during childhood.
There is no general consensus about correlations between FeNO and respiratory function and between FeNO and bronchial hyperresponsiveness (BHR) (32) (33) (34) (35) . The correlations reported thus far can probably be attributed to differences in the subjects investigated. In fact, population homogeneity, different measurement techniques, disease duration (36) , time of suspension of inhaled steroid therapy, atopic status (19) , sensitization and exposure to allergens (27) may influence the results of FeNO, respiratory function and BHR. Asthmatic children with normal respiratory function could be affected by airway inflammation (37) . Horvath and Barnes found high FeNO levels in symptom-free atopic subjects, and concluded that FeNO could be correlated with an early, not clinically apparent state of airway inflammation (38) . Similar results were found in a teenage population (39) , and it was suggested that persistence of subclinical airway inflammation could be a continuous risk of the clinical reappearance of asthma.
EXALED NITRIC OXIDE MEASUREMENT
FeNO can be measured by using chemiluminescence analyzer (chemiluminescence technology) or electrochemical method. The detection limit of the instrument must be from 1 to 5 parts per billion (Ppb) volume, as required by guidelines (40) , with a resolution of 1 ppb. The analyzer should be calibrate daily, using a certifiedNO mixture. The single-breath online measurement method represents the preferred method to record FeNO in children who can cooperate. Children have to inhale to total lung capacity from NO-free air and to exhale a single breath (without nose clip) through a mouthpiece at a mouth pressure of >5 em H 2 0 , corresponding to an expiratory flow of 50 mLis. Mouth pressure was displayed on a computer screen as a prompt for the children to maintain a steady flow. Nitric oxide is measured at the plateau and the measurement has to be rejected if a stable flow is not maintained for at least 6 s of exhalation. Audiovisual aids can facilitate expiratory flow control.
In preschool children, who often have difficulty in maintaining flow rate or pressure within the required limits the offline method with constant flow rate, this tool is the best choice. The child blows air through a mouthpiece into a Mylar or Tedlar balloon, while nasal contamination is prevented by closing the velum by exhaling against at least 5 cmll.O mouth pressure (41) EXHALED NITRIC OXIDE AND RHINITIS Nasal NO concentrations are higher than in the lower respiratory tract (42) probably because nasal NO may have physiologic roles, such as preserving sinus sterility (43) and modulating ciliary motility (44) . In fact, children with primary ciliary dyskinesia and cystic fibrosis have extremely low nasal NO (45) and nasal NO measure may become a useful clinical test (40) . Nasal NO concentration has been proposed as a marker of nasal inflammation in allergic rhinitis, but results are controversial (40, (47) (48) (49) The measurement of nasal NO output requires generation of airflow through the nasal cavity. Flow through the nasal cavities is generally achieved by insufflating air via one naris while the velum is closed, so that air circulates from one naris to the other around the posterior nasal septum (40) .
On the other hand, other studies showed increased FeNO levels in subjects with allergic rhinitis (50, 35) . In a recent study, in non-asthmatic children, only the atopic children with rhinitis had an elevated FeNO, asthmatic children who were not atopic and who did not suffer from rhinitis had a lower FeNO whereas asthmatics with atopy but without rhinitis had a twofold increase in eNO level (51)
CONCLUSION
In conclusion, FENO seems to be a good tool for measuring and monitoring the extent of airway inflammation in asthmatic subjects. Indeed, FENO is closely correlated with other parameters of airway inflammation (21) , inhaled steroids quickly reduce FENO levels (14, 15) , and modification of FENO levels seems to be related to changes in anti-inflammatory therapy (23, 24) . Further studies are needed to understand better the clinical implications of FeNO measurement in children with allergic rhinitis.
